Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 4,175 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control comparison Clear all

Conditions: Type2 Diabetes
Interventions: Digital Storytelling Intervention; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 451 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 3
States / cities: Phoenix, Arizona • Minneapolis, Minnesota • Rochester, Minnesota

Conditions: Human Papillomavirus Virus, HPV
Interventions: Web App Intervention Group, Usual Customary Care Group; Behavioral
Lead sponsor: Klein Buendel, Inc.; Industry
Eligibility: 11 Years and older
Enrollment: 432 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 3
States / cities: Golden, Colorado • Indianapolis, Indiana • Albuquerque, New Mexico

Conditions: Posttraumatic Stress Disorder
Interventions: Cognitive Processing Therapy Group Videoteleconference, Cognitive Processing Therapy Group In-Person; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Contact Lens Wear
Interventions: ASP-57, ReNu® Multiplus; Device
Lead sponsor: Asepticys LLC; Industry
Eligibility: 18 Years and older
Enrollment: 315 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 14
States / cities: Irvine, California • San Diego, California • Longwood, Florida + 11 more

Conditions: Acne Vulgaris
Interventions: FCD105, 3% Minocycline Foam, 0.3% Adapalene Foam, Vehicle Foam; Combination Product · Drug · Other
Lead sponsor: Vyne Therapeutics Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 446 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 35
States / cities: Bryant, Arkansas • Rogers, Arkansas • Encino, California + 32 more

Conditions: Arthrodesis Surgery Involving the Hindfoot or Ankle
Interventions: AMPLEX, Autogenous Bone Graft (ABG); Device · Procedure
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 28
States / cities: Gilbert, Arizona • Phoenix, Arizona • San Francisco, California + 23 more

Conditions: Chickenpox
Interventions: Investigational varicella vaccine low potency, Investigational varicella vaccine medium potency, Investigational varicella vaccine high potency, Licensed varicella vaccine Lot 1, Licensed varicella vaccine Lot 2, Measles, mumps, and rubella vaccine, Hepatitis A vaccine, 13-valent pneumococcal conjugate vaccine; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Months to 15 Months
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 41
States / cities: Bryant, Arkansas • Jonesboro, Arkansas • Little Rock, Arkansas + 37 more

Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: liraglutide, placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Idiopathic Pulmonary Fibrosis (IPF), Sarcoidosis Lung, Pulmonary Hypertension, Usual Interstitial Pneumonia
Interventions: Not listed
Lead sponsor: Cosmos Rx, Inc; Industry
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Pregnancy, Substance Use, Depression, Anxiety
Interventions: Listening to Women and Pregnant and Postpartum People; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 41 Years · Female only
Enrollment: 415 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Rib Fractures, Wounds and Injuries
Interventions: Thoracic epidural catheter placement, Paracostal catheter placement; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 99 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Maternal-Fetal Relations, Mother-Child Relations, Maternal Behavior
Interventions: Mindfulness-Based Childbirth and Parenting, Non-Mindfulness-Based Childbirth Class; Behavioral
Lead sponsor: Heidemarie Laurent; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Champaign, Illinois • University Park, Pennsylvania

Conditions: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Delafloxacin, Vancomycin, Aztreonam, Placebo; Drug
Lead sponsor: Melinta Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 660 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 17
States / cities: Montgomery, Alabama • Anaheim, California • Chula Vista, California + 14 more

Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease
Interventions: Etelcalcetide, Cinacalcet, Oral Placebo, Intravenous Placebo; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 683 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 41
States / cities: Azusa, California • Bakersfield, California • Chula Vista, California + 37 more

Conditions: Tinnitus, Tinnitus, Subjective
Interventions: Cold pack-delivered mild therapeutic hypothermia, Sham (No Treatment); Device
Lead sponsor: Restorear Devices LLC; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Bozeman, Montana

Conditions: Pain
Interventions: Preservative free morphine, Fentanyl; Drug
Lead sponsor: Goodman, Evan, M.D.; Individual
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Aromatase Inhibitor, Musculoskeletal Symptoms, Postmenopausal Breast Cancer Survivors
Interventions: APA, Sham APA control, Education control; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Dermatitis Atopic
Interventions: Amlitelimab, Placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 12 Years and older
Enrollment: 1,541 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 82
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Tucson, Arizona + 67 more

Conditions: Type 2 Diabetes Mellitus
Interventions: placebo, GSK376501; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Evansville, Indiana

Conditions: Kidney Failure, Chronic, Anemia, Iron-Deficiency
Interventions: iron sucrose injection, USP, sodium ferric gluconate complex in sucrose injection; Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 12
States / cities: Phoenix, Arizona • Alhambra, California • Bell Gardens, California + 9 more

Conditions: Inflammation
Interventions: Difluprednate, Placebo; Drug
Lead sponsor: Sirion Therapeutics, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 219 participants
U.S. locations: 1
States / cities: Washington, Missouri

Conditions: Cardiac Surgical Procedures
Interventions: Multi-modal Opioid Sparing Pain Management Protocol; Other
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Back Pain, Surgery-Complications, Narcotic Use, Physical Stress, Post Operative Pain
Interventions: Exparel, Bupivacain; Drug
Lead sponsor: Foundation for Orthopaedic Research and Education; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Dry Eye Syndromes
Interventions: Dextenza 0.4Mg Intracanalicular Insert, Over the counter Artificial tears; Drug · Other
Lead sponsor: The Eye Centers of Racine and Kenosha; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Racine, Wisconsin

Search by objective public record fields.

Stories for Change: Digital Storytelling for Diabetes Self-Management Among Hispanic Adults

Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake

Telemental Health and Cognitive Processing Therapy for Rural Combat Veterans With Posttraumatic Stress Disorder

A Safety and Effectiveness Study of a New Multi-Purpose Contact Lens Care Solution

A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

AMPLEX Ankle Fusion and Hindfoot

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age

Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group

A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension

Pilot Randomized Controlled Trial (RCT): Remote SBIRT Vs. In-Person SBIRT

Comparison of Epidural and Paracostal Catheter Placement for Pain Control After Rib Fractures

Neurobehavioral Effects of Prenatal Mindfulness Training on Maternal Presence and Compassionate Love

Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

External Therapy for Tinnitus Management

Epidural Morphine Versus Epidural Fentanyl Infusion Following Cesarean Section

Auricular Point Acupressure to Self-Manage Chronic Pain or Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors: Effectiveness and Scientific Underpinnings

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

Comparison Between Effects of Two Iron Preparations on Protein in the Urine

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)

Opioid Sparing Pain Management Strategy

Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion

ACCURATE Study for Subjects With Dry Eyes